You are here

CAR-T

8 Biotech Stock Controversies Emerging From 'JPM15' Conference

TheStreet.com

Tue, 01/20/15 - 11:33 am

Gilead Sciences

immuno-oncology

Duchenne Muscular Dystrophy

Kite Pharma/Amgen: A Strong Combination

Seeking Alpha

Thu, 01/15/15 - 05:50 pm

Juno Therapeutics

After CAR-T: Getting Ahead of the Next Hot Trend in Cancer Stocks

TheStreet.com

Tue, 01/6/15 - 08:56 am

Juno Therapeutics

Cellectis Is Late To The CAR-T Cell Race, But Could Finish First

Seeking Alpha

Fri, 01/2/15 - 07:33 pm

Bellicum pulls off a $140M IPO as CAR-T has its day on Wall Street

Fierce Biotech

Thu, 12/18/14 - 10:26 am

Bellicum battles for CAR-T spotlight with a $121M IPO pitch

Fierce Biotech

Thu, 12/11/14 - 07:31 pm

The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting

TheStreet.com

Mon, 12/8/14 - 10:30 am

Agios Pharmaceuticals

Bristol-Myers Squibb

Seattle Genetics

JNJ, Transposagen To Co-Develop CAR-T Therapy

Bidness Etc.

Tue, 11/25/14 - 11:04 am

cancer immunotherapy

Juno takes its hot CAR-T cancer tech to Wall Street in $150M IPO

Fierce Biotech

Mon, 11/17/14 - 04:07 pm

Juno Therapeutics

Novartis commits $20M to build a new CAR-T development center at Penn

Fierce Biotech

Fri, 09/12/14 - 08:39 am

Kite Pharma soars on added evidence that CAR-T treatment quells cancer

Fierce Biotech

Tue, 08/26/14 - 08:32 am

B cell malignancies

Is Pfizer Putting the Car-T Before the Horse?

Motley Fool

Thu, 06/19/14 - 05:43 pm

Pages